SCHEMBL10567229

SCHEMBL10567229

CC1(C)C(=O)Nc2cc3[nH]c(-c4ccco4)nc3cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.56
PDE4B Q07343 1/20 0.56
PDE4C Q08493 1/20 0.56
PDE4D Q08499 1/20 0.56
PDE3B Q13370 1/20 0.56
PDE3A Q14432 1/20 0.56
AURKA O14965 1/20 0.52
AURKB Q96GD4 1/20 0.52
CHEK1 O14757 1/20 0.51
LIMK1 P53667 1/20 0.51
CDK5 Q00535 1/20 0.51
CLK4 Q9HAZ1 1/20 0.51
ALOX5 P09917 1/20 0.50
EPHX2 P34913 1/20 0.50
ALDH1A1 P00352 5/20 0.48
RAB9A P51151 4/20 0.48
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 4/20 0.47
POLB P06746 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10568502 0.85 ALOX5 (0.47) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10375588 0.80 PDE4A (0.71) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10530446 0.79 CHEK1 (0.49) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10569087 0.77 PDE3B (0.57) PDE4APDE4BPDE4CPDE4DPDE3B
Adibendan SCHEMBL9832050 0.77 PDE3B (0.90) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10566678 0.76 AURKA (0.61) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL6451499 0.76 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10566333 0.76 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9559361 0.76 KDM4E (0.51) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10373592 0.76 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4835280-A Indoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazoles BOEHRINGER MANNHEIM GMBH (DE) 1989-05-30 US disclosed
US-4695567-A Pyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1987-09-22 US disclosed
EP-0189103-A2 Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates Roche Diagnostics GmbH (DE) 1986-07-30 EP disclosed